We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Michael J. Molumby is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2019 — 2020 |
Molumby, Michael Jacob |
F32Activity Code Description: To provide postdoctoral research training to individuals to broaden their scientific background and extend their potential for research in specified health-related areas. |
Identifying Mechanisms Regulating Neuronal Homeostasis and Cell-Type Specific Trna Expression in the Mammalian Brain @ University of California, San Diego
Growing evidence indicates that ribosome processivity during the translation of mRNA to proteins is exquisitely sensitive to changes in tRNA expression and processing. Perturbation of these processes contribute to aberrant cellular homeostasis that manifests as cancer or neurodegeneration. In a N-ethyl-N-nitrosourea (ENU) mutagenesis forward genetic screen in C57BL/6J (B6J) mice to identify novel genes regulating neuronal homeostasis, my lab identified a new ribosome rescue protein GTPBP2. Additionally, we identified a mutation in n-Tr20, a tRNAArgUCU that is specifically expressed in neurons, in B6J mice that epistatically interacts to cause neurodegeneration in Gtpbp2-/- mice. This mutation reduces the processing of n-Tr20 which in turn reduces the total pool of tRNAArgUCU in the brain causing ribosome stalling that is normally rescued by wild type GTPBP2. Interestingly, expression of n-Tr20 is restricted to the brain. These results established ribosome stalling as a novel mechanism for neurodegeneration and defined n-Tr20 as the first reported neuron-specific tRNA in vertebrates. Subsequent mapping crosses of B6J-Gtpbp-/- mice have identified a BALB/cByJ-derived locus that enhances neurodegeneration. Although we have narrowed the critical region containing this modifier gene, no causal gene or mechanism have been identified. In Aim 1 of this proposal, I have proposed a research strategy to identify the causative gene for this locus and elucidate the mechanisms by which this modifier gene augments neurodegeneration. In Aim 2, I will investigate the prevalence of cell-type tRNA expression in the brain by generating the first in vivo tRNA expression brain atlas. I will accomplish this aim by first generating a knock-in mouse line to conditionally epitope-tag RNA Polymerase III (Pol III), the RNA polymerase responsible for transcribing all tRNA, and then performing ChIP-sequencing to determine the occupancy of Pol III machinery on tRNA genes isolated from specific cell-types. With the completion of this proposal we expect to reveal the vast complexity of cell-type specific tRNA profiles in the mammalian brain, and new mechanisms of dysregulation that contribute to aberrant ribosome processivity and neuronal homeostasis in specific cell-types.
|
0.976 |